Latest from Healthcare

Concepta will be developing products for the female health diagnostics sector

Pregnancy test technology secures £2.3 million through Angel CoFund led deal

Concepta will now being to develop and market a diagnostic device for the testing of fertility, pregnancy and early-stage healthy pregnancy monitoring following a new funding round.

Zesty started with dentist appointments and then branched out

Dental booking platform Zesty banks funding and looks to new healthcare markets

Investment firms TA Ventures and ABRT Venture Fund are coming together to lead a $2 million investment into healthcare booking platform Zesty.

Albert Medical Devices is looking to revolutionise the traditional catheter

Angel CoFund invests in 40th company as it pairs up with London Business Angels

A medical devices company based in Liverpool has become the latest business to receive equity backing from the government's Angel CoFund.

Venture Life has posted solid growth in a market growing in the western world

Venture Life joins AIM to fund ageing population product development

A business directed towards the developing of products for an ageing population has joined the AIM market of the London Stock Exchange.

Doctor to entrepreneur: Alastair Buick set up Meducation with Jeremy Walker

Bootstrapped Meducation closes first funding round and banks $1 million

Education technology start-up Meducation has courted the interest of a number of private investors in closing a $1 million seed funding round.

Futura Medical is looking to take its sexual health products into new markets

Sexual performance enhancement healthcare company raises £12 million

Healthcare business Futura Medical has used its AIM listing to raise new funds for growth of its sexual health and pain relief products.

Michelson is involved in the diagnosis of conditions such as skin cancer

Michelson Diagnostics closes new venture capital and angel deal

Venture capital investor Octopus Investments has backed Michelson Diagnostics again through a £1.98 million round.

It is hoped that the new treatment will cut down on pre-eclampsia

Metabolomic Diagnostics finds two backers for maiden funding round

A seed funding round worth €750,000 has been closed by Irish business Metabolomic Diagnostics to help with growth.

Healthcare: Part of Medicina's product range are syringes used for IVs

Northern healthcare deal for the Business Growth Fund takes 2013 regional outlay to £35 million

The Business Growth Fund has continued with its active year-end dealmaking by investing in medical devices business Medicina.

Benchmark manufactures and commercialises animal health vaccines

Biggest healthcare fundraising of the year as Benchmark joins AIM

An animal health, technical publishing and sustainability science business has joined London's Alternative Investment Market.

Sector surge: August Equity expects the dementia market to grow considerably

August Equity closes second deal from its new fund by investing in dementia care market

Specialist investor August Equity has made a new acquisition from its Partners III fund and added a social care business to its portfolio.

Healthcare IT: Civic's software is for the clinical trials market

Albion Ventures makes another healthcare IT play through SaaS firm Cisiv

US-based investor Albion Ventures has expanded its SaaS portfolio by backing healthcare offering Cisiv.

MedPlast is hoping to grow its customer base and global strategic footprint

UK acquisition for US private equity firm Baird Capital

Baird Capital portfolio company MedPlast has snapped up UK-based Orthoplastics for an undisclosed amount.

Aridhia combines information technology, health informatics and analytics

From digital marketing to biomedical informatics in a week for Scottish Equity Partners

Scottish Equity Partners has closed its second deal in a week by investing in Aridhia Informatics alongside fellow VC Albion Ventures.

Healthcare market: The surgery tool has achieved good early traction

Angel CoFund backs surgery tool for the second time to help with world growth

A new technology aimed improving the speed of surgical procedures has closed the first stage of a £2.5 million funding round.

Quality of life: Acacia Pharma is developing products aimed at supportive care

British medical company Acacia Pharma secures £15 million funding

A Series B venture capital financing round worth £15 million has been led by Fidelity Biosciences and Novo A/S.

New approach: There is no need for fridges or freezers with Biofortuna technology

Biofortuna secures more venture capital cash to ramp up US efforts

Molecular diagnostics business Biofortuna has closed another round of venture capital funding so that it can target the US market.

High street: Chemists in the UK are growing revenues by adding new products

Private equity looks to pharmacy market for solid returns through consolidation

The steady income streams and low risk profiles of pharmacy businesses are proving increasingly attractive for private equity investors, new figures suggest.

Practice Plan will be adding to Wesleyan Assurance Society's dental offering

Practice Plan finds new home with trade buyer after Dunedin Private Equity exit

An eight-year involvement with dental membership plan business Practice Plan has netted Dunedin Private Equity a 2.8x return on its investment.

Olympian: Sir Chris Hoy is an official brand ambassador for Sport in Science

Sports nutrition business used by Sir Chris Hoy joins London's junior exchange

Science in Sport is targeting its share of a reported £19.6 billion global market in 2010 by securing a stock market listing.

More from GrowthBusiness

The Entrepreneur

Expert view: Business plans are the new novels, says Richard Reed

Innocent Drink’s Richard Reed on life after a $500 million company

At the beginning of 2013 Richard Reed and the rest of his founding team at Innocent Drinks sold out the last of their stake to Coca Cola. GrowthBusiness finds out what happens after exiting a business valued at $500 million.

Growing A Business

MINT nations: (Clockwise from top left) Mexico, Indonesia, Turkey and Nigeria

The emerging markets worth a MINT

Glenn Porter, general manager international identity verification at GBGroup, examines the opportunities and risks of trading with the MINT population of Mexico, Indonesia, Nigeria and Turkey.

Comment & Analysis

Securing funding for cleantech ventures

Cleantech businesses and projects are notoriously difficult to get off the ground, with cyclical changes in the cost-effectiveness and market potential for technologies having a big impact.

Research

Directors' Pay on AIM 2014

The most complete review of directors' remuneration on AIM.